Stock Report

Download full stock data and analysis for free Last Updated: 31-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Trinity Biotech - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$9.68

up-down-arrow $-0.07 (-0.72%)

As on 28-Aug-2026 16:04EDT

Market cap

info icon

$8 Mln

Revenue (TTM)

info icon

$54 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- 46.04 -28.87 -11.20 -15.56
EBIT -- 37.82 -28.20 -9.69 -389.66
Net Profit -- -98.36 -17.58 2.86 -230.95
EPS -- -94.88 10.69 17.63 -401.43
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -43.66-30.35-54.96-30.49-45.53
Net Margin info ----------
Return on equity info 120.38715.7969.76107.52183.87
Return on Capital info -52.48-41.02-56.81-58.30-42.32
Return on Assets info -35.54-28.96-35.86-39.07-31.70
Debt to Equity (x) info -----1.92-2.86-2.82

Profitability

View Detailed Peer Comparison

ROCE

-56.81

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-56.81
-58.30
-42.32
-48.56
0.87
Peer Median
--
--
--
--
--
ROE

69.76

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
69.76
107.52
183.87
3,286.73
-68.95
Peer Median
--
--
--
--
--
ROA

-35.86

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-35.86
-39.07
-31.70
-38.86
0.70
Peer Median
--
--
--
--
--
EBIT Margin

-54.96

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-54.96
-30.49
-45.53
-30.46
9.67
Peer Median
--
--
--
--
--
Net Margin

-85.36

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-85.36
-51.64
-42.26
-65.58
1.08
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.29

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-0.29
0.08
-0.09
-0.23
-0.20
Peer Median
--
--
--
--
--
EBIT Growth

-28.20

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-28.20
27.46
-35.85
-342.69
6,550.85
Peer Median
--
--
--
--
--
Net Profit Growth

-17.58

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-17.58
-32.35
41.42
-4,785.94
113.70
Peer Median
--
--
--
--
--
EPS Growth

0.11

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
0.11
-23.86
0.98
-33.29
21.86
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-1.92

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-1.92
-2.86
-2.82
-33.18
-310.84
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-1.54

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-1.54
-0.07
-0.08
-0.87
-267.37
Peer Median
--
--
--
--
--
Current Ratio

0.25

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
0.25
1.28
2.60
2.69
0.72
Peer Median
--
--
--
--
--
Quick Ratio

0.12

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
0.12
0.68
1.27
1.39
0.43
Peer Median
--
--
--
--
--
Interest Coverage

-1.83

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-1.83
-1.96
-2.55
-0.77
1.11
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

23.48

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
23.48
23.73
23.54
25.04
19.36
Peer Median
--
--
--
--
--
Asset Turnover

0.42

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
0.42
0.76
0.75
0.59
0.65
Peer Median
--
--
--
--
--
Receivable days

103.80

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
103.80
83.03
93.30
91.61
90.71
Peer Median
--
--
--
--
--
Inventory Days

259.37

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
259.37
178.95
207.32
178.80
197.44
Peer Median
--
--
--
--
--
Payable days

124.32

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
124.32
48.80
49.29
44.91
46.14
Peer Median
--
--
--
--
--
Cash Conversion Cycle

238.85

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
238.85
213.18
251.32
225.50
242.02
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-0.01

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-0.01
-0.01
-0.16
-0.01
0.29
Peer Median
--
--
--
--
--
Price / Book Value

-0.01

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-0.01
-0.01
-0.16
-0.12
-0.78
Peer Median
--
--
--
--
--
EV/EBITDA

-6.24

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Trinity Biotech - ADR
-6.24
-5.68
-2.80
-3.94
6.94
Peer Median
--
--
--
--
--
loading...
loading...